Literature DB >> 34298091

Acinetobacter baumannii strains isolated from cerebrospinal fluid (CSF) and bloodstream analysed by cgMLST: the dominance of clonal complex CC92 in CSF infections.

Tao Chen1, Ying Fu1, Xiaoting Hua1, Qingye Xu1, Peng Lan1, Yan Jiang1, Yunsong Yu2, Zhihui Zhou3.   

Abstract

A total of 54 unique clinical Acinetobacter baumannii strains isolated from cerebrospinal fluid (CSF) together with 21 bloodstream isolates collected from five tertiary hospitals in East China between April 2013 and November 2016 were studied for antimicrobial susceptibility patterns and the prevalence of antimicrobial resistance genes. Molecular epidemiological characteristics of CSF isolates and the phylogenetic relationship of isolates from different sources were assessed using multilocus sequence typing (MLST) and core genome MLST (cgMLST). Of the 54 CSF isolates, 51 (94.4%) were blaOXA-23-carrying carbapenem-resistant A. baumannii. Their average resistance rate to different classes of antibiotics was extremely high (>90%), except for tigecycline and colistin. According to the Oxford MLST scheme, all CSF isolates fell into 10 defined sequence types (STs) and 4 novel STs. ST195 and ST208 were the leading STs in isolates from either source. A total of 50 CSF isolates and 20 bloodstream isolates were assigned to clonal complex 92 (CC92), revealing a wild distribution of CC92 in the hospitals of East China. In combination with epidemiological data linked in time and space, cgMLST results elucidated intrahospital and interhospital polyclonal dissemination of A. baumannii causing meningitis. Based on cgMLST, there was no correlation between phylogeny and the source of isolation of A. baumannii. These results emphasise that the genetic potential of this pathogen is vast enough to infect multiple human body sites.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CC92; CRAB; Carbapenem-resistant Acinetobacter baumannii; Core genome MLST; Multilocus sequence typing; Nosocomial meningitis

Mesh:

Substances:

Year:  2021        PMID: 34298091     DOI: 10.1016/j.ijantimicag.2021.106404

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  3 in total

1.  Acinetobacter baumannii Genomic Sequence-Based Core Genome Multilocus Sequence Typing Using Ridom SeqSphere+ and Antimicrobial Susceptibility Prediction in ARESdb.

Authors:  Madiha Fida; Scott A Cunningham; Stephan Beisken; Andreas E Posch; Nicholas Chia; Patricio R Jeraldo; Matthew P Murphy; Nicole M Zinsmaster; Robin Patel
Journal:  J Clin Microbiol       Date:  2022-07-12       Impact factor: 11.677

2.  In Vitro Activity of KBP-7072 against 536 Acinetobacter baumannii Complex Isolates Collected in China.

Authors:  Renru Han; Li Ding; Yang Yang; Yan Guo; Dandan Yin; Shi Wu; Peiyuan Zhi; Demei Zhu; Qingmei Liu; Xiaojuan Tan; Yuanju Zhu; Jay Zhang; Li Li; Fupin Hu
Journal:  Microbiol Spectr       Date:  2022-02-09

3.  Whole genome sequencing of OXA-232-producing wzi93-KL112-O1 carbapenem-resistant Klebsiella pneumoniae in human bloodstream infection co-harboring chromosomal ISEcp1-based bla CTX-M-15 and one rmpA2-associated virulence plasmid.

Authors:  Chongmei Tian; Mengyu Xing; Yaping Zhao; Xueyu Fan; Yongfeng Bai; Liping Fu; Siwei Wang
Journal:  Front Cell Infect Microbiol       Date:  2022-09-29       Impact factor: 6.073

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.